Definitive Contract 75A50119C00032

Award Date 4/2/19
Potential Completion Date 4/30/21
Potential Value $689K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Great Britain, United Kingdom
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $849,451 firm fixed price delivery order to Protein Sciences Corporation under the Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ contract. The delivery order is for the manufacture of master/working seed lot(s), research lot(s), and analytical laboratory testing/assay(s) to be performed in Meriden, Connecticut through June 2021. No subcontractors or set aside...
The Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response awarded Protein Sciences Corporation a $125,260 firm fixed price delivery order against the Pandemic Influenza Preparedness and Response 2016-2021 master IDIQ contract. This order calls for Protein Sciences to conduct storage and stability testing of antigen final containers in the National Pre-Pandemic Vaccine Stockpile. Specifically, the contractor will test RH7 A Guangdong final...
The Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $800,855.47 Firm Fixed Price Delivery Order contract to Seqirus Inc., a foreign-owned for-profit manufacturer of goods. The contract supports Seqirus' ongoing work to provide goods and services related to pandemic preparedness and response, including supply of bulk antigens, adjuvants, influenza seed strains, and storage and testing for the National Pre-Pandemic...
This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer, to acquire medical countermeasures for pandemic influenza preparedness and response. The $1,056,500.00 award is under ASPR's Pandemic Influenza Preparedness and Response 2012-2016 indefinite delivery vehicle (IDV), a $5.87 billion IDIQ that enables...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a firm fixed price Delivery Order contract to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer, for the supply of H7N9 bulk lots. The $40,642,758.00 award is part of the Pandemic Influenza Preparedness and Response 2016-2021 Indefinite Delivery Vehicle, which has a potential value of $5.87 billion and enables the government to quickly acquire medical countermeasures...
This federal contract award, with an ID of HHSO100201200015I|HHSO10033012T, was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR) to Sanofi Pasteur Inc. The $5,686,074.95 firm fixed-price contract is for the storage of H5N1 and H7N9 influenza antigen bulk lots and H7N9 final containers during calendar year 2015. This award is a delivery order under the Pandemic Influenza Preparedness and Response 2012-2016 Indefinite Delivery Vehicle (IDIQ) contract, which...
The Department of Health and Human Services' Biomedical Advanced Research and Development Authority awarded a $269,952,453 firm fixed price definitive contract to Global Health Investment Corporation, a nonprofit organization. This contract establishes a public-private partnership through BARDA's other transaction authority to address gaps in pandemic preparedness and response. Specifically, the partnership will foster and accelerate medical countermeasure development using strategic venture...
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $454,698.72 delivery order contract to Sanofi Pasteur Inc. for the purpose of providing medical countermeasures such as vaccines and adjuvants for pandemic preparedness and response or as required in response to a HHS designated event. The contract is a firm fixed price order that will be performed by Sanofi Pasteur Inc.'s Swiftwater, Pennsylvania division from February 22,...
This is a federal contract award made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), part of the U.S. Department of Health and Human Services (HHS), to Venatorx Pharmaceuticals Inc., a biopharmaceutical company specializing in the discovery and development of novel anti-infective therapeutics. The contract, valued at $147,481,537.00, does not have a set-aside designation and was awarded as a definitive, cost-sharing contract. The work under this contract focuses...
The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a $680,955.00 firm fixed price delivery order contract to Sanofi Pasteur Inc. for the acquisition of egg-based influenza master and working seed lots derived from a specific A/American Wigeon/South Carolina/22-000345-001/2021 (H5N1) candidate vaccine virus, as well as the fill-finish of any existing egg-based A/American Wigeon/South Carolina/22-000345/2021...

The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response awarded a $688,863 firm-fixed price contract to Avaxzipen LIMITED, doing business as Enesi Pharma, for the evaluation of novel solid dose vaccines for use in a future pandemic influenza. This contract was awarded under the Pandemic and All Hazard Preparedness Act and Pandemic and All Hazard Preparedness Reauthorization Act, which authorizes the Office of Biomedical Advanced Research and Development Authority (BARDA) to accelerate innovations and improve the availability of transformative products and technologies to protect Americans from health security threats. The contract has an end date of April 30, 2021 and was not set aside for a specific business classification.

Generated 3/22/24, 2:27 AM